Skip to content
ETopical – Lifestyle
Author:
Alamar Biosciences, Inc.
Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026
October 8, 2026
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
October 5, 2026
Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment
September 24, 2026
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
September 1, 2026
Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures
August 10, 2026
Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance
August 10, 2026
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026
July 14, 2026
Alamar Biosciences Reports First Quarter 2026 Financial Results
May 8, 2026
Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference
May 5, 2026
Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026
April 30, 2026
1
2
Next Page
→